Regentatlantic Capital LLC Becton Dickinson & CO Transaction History

Regentatlantic Capital LLC

$3.34 Billion
Q3 2022

A detailed history of Regentatlantic Capital LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Regentatlantic Capital LLC holds 10,802 shares of BDX stock, worth $2.45 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,802

Previous 10,423 3.64%

Holding current value

$2.45 Million

Previous $2.57 Million 6.34%

% of portfolio

0.07%

Previous 0.08%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $19,340 - $100,143	379 Added 3.64%	10,802 $2.41 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $116,431 - $136,608	496 Added 5.0%	10,423 $2.57 Million
Q1 2022 May 02, 2022	BUY	$243.64 - $270.48 $172,497 - $191,499	708 Added 7.68%	9,927 $2.64 Million
Q4 2021 Jan 27, 2022	BUY	$230.08 - $250.94 $52,228 - $56,963	227 Added 2.52%	9,219 $2.32 Million
Q3 2021 Nov 15, 2021	BUY	$232.72 - $256.47 $158,947 - $175,169	683 Added 8.22%	8,992 $2.21 Million
Q2 2021 Aug 12, 2021	BUY	$232.65 - $254.58 $18,379 - $20,111	79 Added 0.96%	8,309 $2.02 Million
Q1 2021 Apr 29, 2021	BUY	$232.09 - $256.88 $239,748 - $265,357	1,033 Added 14.35%	8,230 $2 Million
Q4 2020 Feb 04, 2021	BUY	$221.92 - $245.94 $41,942 - $46,482	189 Added 2.7%	7,197 $1.8 Million
Q3 2020 Oct 13, 2020	BUY	$215.77 - $276.76 $65,162 - $83,581	302 Added 4.5%	7,008 $1.63 Million
Q2 2020 Aug 13, 2020	BUY	$219.9 - $263.41 $187,354 - $224,425	852 Added 14.55%	6,706 $1.61 Million
Q1 2020 May 14, 2020	SELL	$195.69 - $279.01 $139,135 - $198,376	-711 Reduced 10.83%	5,854 $1.35 Million
Q4 2019 Feb 04, 2020	SELL	$236.45 - $266.82 $17,497 - $19,744	-74 Reduced 1.11%	6,565 $1.79 Million
Q3 2019 Oct 22, 2019	SELL	$230.58 - $256.08 $3,689 - $4,097	-16 Reduced 0.24%	6,639 $1.68 Million
Q2 2019 Jul 23, 2019	BUY	$217.4 - $246.08 $268,054 - $303,416	1,233 Added 22.74%	6,655 $1.68 Million
Q1 2019 May 03, 2019	SELL	$206.05 - $248.17 $200,898 - $241,965	-975 Reduced 15.24%	5,422 $1.35 Million
Q4 2018 Jan 30, 2019	BUY	$204.73 - $257.93 $145,972 - $183,904	713 Added 12.54%	6,397 $1.44 Million
Q3 2018 Oct 30, 2018	BUY	$233.07 - $256.0 $235,633 - $258,816	1,011 Added 21.63%	5,684 $1.48 Million
Q2 2018 Jul 31, 2018	SELL	$208.1 - $233.85 $11,445 - $12,861	-55 Reduced 1.16%	4,673 $1.12 Million
Q1 2018 Apr 23, 2018	SELL	$205.46 - $240.27 $8,834 - $10,331	-43 Reduced 0.9%	4,728 $1.03 Million
Q4 2017 Jan 23, 2018	BUY	$189.0 - $222.64 $55,755 - $65,678	295 Added 6.59%	4,771 $1.02 Million
Q3 2017 Oct 25, 2017	BUY	$186.89 - $198.9 $836,519 - $890,276	4,476	4,476 $877,000

Others Institutions Holding BDX

# of Institutions

1,738

Shares Held

249M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regentatlantic Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regentatlantic Capital LLC with notifications on news.

Account

Regentatlantic Capital LLC Becton Dickinson & CO Transaction History